大分割与常规分割改良根治术后放疗对乳房重建患者并发症的影响
该回顾性研究纳入396例乳腺癌术后乳房重建并接受辅助PMRT的患者,比较大分割与常规分割放疗的乳房相关并发症。结果显示两种分割方案的主要乳房相关并发症无显著差异,大分割组主要挛缩发生率显著更低;PMRT与最终延期重建间隔>10个月者主要并发症发生率显著更低。
要点
- 大分割与常规分割PMRT在乳房重建患者中主要乳房相关并发症无显著差异。
- 大分割放疗未增加主要伤口问题(感染和裂开),且主要挛缩发生率显著更低。
- PMRT与最终延期重建间隔>10个月者主要乳房并发症发生率显著更低。
核心结论
- 大分割放疗在乳房重建乳腺癌患者中乳房相关并发症与常规分割放疗相当,与重建类型无关。
- 需正在进行的随机试验证实该发现。
研究设计与样本
- 回顾性研究,纳入2009年至2018年间396例乳腺癌术后乳房重建并接受辅助PMRT的患者。
- 267例接受即刻重建,129例接受延期重建;按重建时机和重建类型分析乳房相关并发症。
- 主要乳房并发症定义为放疗结束后需再手术或再住院的乳房相关毒性。
主要发现
- 中位随访35.3个月(范围8.8-122.7个月)。
- 即刻重建组中,常规分割91例、大分割176例,两组主要乳房相关并发症发生率无显著差异。
- 大分割组主要伤口问题(感染和裂开)未增加,主要挛缩发生率显著更低。
- 延期重建组中,常规分割48例、大分割81例,两组主要乳房并发症发生率无差异,1期或2期延期重建均无差异。
- PMRT与最终确定性重建间隔>10个月者主要乳房并发症发生率显著更低。
关键数值与推荐
- 主要乳房并发症定义为放疗结束后需再手术或再住院的乳房相关毒性。
- PMRT与最终确定性重建间隔>10个月与主要乳房并发症发生率显著更低相关。
临床怎么用
- 对于接受乳房重建的乳腺癌患者,大分割PMRT可作为与常规分割相当的选项,不增加主要乳房相关并发症。
- 延期重建前接受PMRT者,可考虑将PMRT与最终重建间隔>10个月以降低主要乳房并发症风险。
局限性
- 回顾性研究设计。
- 研究结论需正在进行的随机试验证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to compare breast-related complications between hypofractionated adjuvant postmastectomy radiation therapy (PMRT) and conventional fractionated radiation therapy (RT) in patients with breast cancer undergoing reconstruction by reconstruction surgery type. METHODS AND MATERIALS: Data from a total of 396 patients with breast cancer who underwent breast reconstruction after mastectomy between 2009 and 2018 were retrospectively reviewed. All patients received adjuvant PMRT according to either a conventional fractionation or hypofractionation schedule. We analyzed breast-related complications according to the timing of breast reconstruction (immediate or delayed). In cases of delayed reconstruction, only PMRT delivered before final delayed reconstruction was included. A major breast complication was defined as a breast-related toxicity that required reoperation or rehospitalization after the end of RT. RESULTS: The median follow-up time was 35.3 months (range, 8.8-122.7 months). Of all patients, 267 received immediate breast reconstruction and 129 received delayed breast reconstruction. In patients with immediate breast reconstruction, 91 were treated with conventional RT and 176 received hypofractionated RT. The occurrence of major breast-related complications did not differ significantly between the 2 fractionation regimens. Hypofractionated RT did not increase major wound problems (infection and dehiscence) compared with conventional RT. Furthermore, major contracture occurred significantly less frequently in hypofractionated RT. Of the patients who had delayed breast reconstruction, 48 received conventional RT and 81 received hypofractionated RT. There was no difference in the incidence of major breast complications between these 2 RT groups, and no difference in major breast complications were reported for either 1- or 2-stage delayed reconstruction. A time interval of >10 months between PMRT and final definitive reconstruction had a significantly lower incidence of major breast complications. CONCLUSIONS: Hypofractionated RT appears to be comparable with conventional fractionated RT in terms of breast-related complications in patients with breast cancer undergoing reconstruction, regardless of breast reconstruction type. An ongoing prospective randomized trial should confirm our findings.
引用
- Kim DY, Park E, Heo CY, et al. Influence of Hypofractionated Versus Conventional Fractionated Postmastectomy Radiation Therapy in Breast Cancer Patients With Reconstruction. Int J Radiat Oncol Biol Phys. 2021. PMID: 34610389. doi:10.1016/j.ijrobp.2021.09.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。